Scott Uhlrich on personalised gait retraining for knee osteoarthritis

Mark Hancock on low back pain

Vibeke Strand on polymyalgia rheumatica

Xue Li on access to biologics in the Asia-Pacific region

Sinisa Savic on treatment outcomes in VEXAS syndrome

Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy

Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus

Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease

Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease

Brooke Conley and Ivan Lin on the development of arthritis educational resources for Aboriginal and Torres Strait Islander peoples in Australia

Mark Russell and Sherry Yang on the inequities in rheumatological care in the UK and USA

Quirine Dumoulin on the 4-year data from the TREAT-EARLIER trial

Sebastian Sattui on older adults with ANCA-associated vasculitis

Celebrating 5 years of The Lancet Rheumatology with Oliver Distler, Laura Coates, and David Liew

Karen Schreiber, Ian Giles, and Angela Tincani on the Pregnancy and Rheumatic Diseases Series

Dr Maria Tektonidou on cardiovascular risk factors in systemic lupus erythematosus

Rosemary Hollick on improving services for adults with rare autoimmune rheumatic diseases

Clinical Realities: Heather Van Epps, Anna Clark, Lola Falasinnu, David Liew, and Puja Mehta

Clinical Realities: Sex and Gender in Research Design and Reporting from The Lancet Summit

Clinical Realities: Randy Cron, Chandrika Bhat, and Puja Mehta